Prime Peptides Cagrilintide is a novel long-acting acylated amylin analogue that acts as a nonselective agonist for amylin receptors (AMYR) and calcitonin G protein-coupled receptors (CTR). This research compound demonstrates significant potential in weight loss studies and food intake reduction applications.
The prime peptides formulation shows particular promise for obesity-related research applications. As a synthetic peptide analog, it offers researchers a stable and consistent compound for investigative studies.
This prime peptides product is supplied as a white freeze-dried powder with purity exceeding 99%. The material is carefully processed and packaged to maintain stability and quality for research purposes.
Note: This product is intended for research use only, not for human consumption or therapeutic applications.